Eric Zhang

Chief Executive Officer at

AKSO Biopharmaceutical, Inc.

45 year

Health Technology

Consumer Services

Profile

Eric Zhang is the founder of AKSO Biopharmaceutical, Inc. Prior to founding AKSO Biopharmaceutical, he worked as a Director at Versartis, Inc. He also worked as a Director at Aravive Biologics, Inc. from 2016 to 2018.
From 2018 to 2023, he served as an Independent Director at Aravive, Inc. Mr. Zhang received his undergraduate degree from Queen's University.

Eric Zhang active positions

Companies	Position	Start
AKSO Biopharmaceutical, Inc.	Chief Executive Officer	-

All active positions of Eric Zhang

Former positions of Eric Zhang

Companies	Position	End
ARAVIVE, INC.	Director/Board Member	2023-10-01
Aravive Biologics, Inc. Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Deals with development of biopharmaceutical industry	Director/Board Member	2018-09-30
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders	Director/Board Member	-

See the detail of Eric Zhang's experience

Training of Eric Zhang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eric Zhang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Queen's University Queen's University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders	Health Technology
Aravive Biologics, Inc. Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Deals with development of biopharmaceutical industry	Health Technology
Aravive, Inc. Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies	Health Technology
AKSO Biopharmaceutical, Inc.

See company connections